ABSTRACT
INTRODUCTION
Oxygen may induce many human diseases despite its importance in survival (1) . For example, atherosclerosis (2) , liver diseases (3), inflammatory-immune injuries (4, 5) , and some eye diseases (6) may be initiated or exacerbated by oxygen and its derivatives. Neuronal death observed in ischemia and stroke (7), Alzheimer's disease (8, 9 ), Parkinson's disease (10, 11) , and ALS (12) may also result from oxidative stress. Oxidative stress arises from an excessive production or decreased clearance of reactive oxygen species (ROS), resulting in accumulation of ROS, cellular damage, and eventual cell death.
Sources of ROS in cells include oxygenases, oxidases, and nitric oxide synthetases (13) . Mitochondria also produce a significant level of ROS during normal respiration as well as during cell death (13, 14) .
Molecules in the cell that can eliminate ROS include catalase and glutathione peroxidases and the nonenzymic, small antioxidants glutathione (GSH), vitamin C, and vitamin E (13).
Molecular and cellular events underlying neuronal death induced by oxidative stress have been characterized in the hippocampal cell line HT-22 and cortical neurons (15) (16) (17) (18) . This pathway of programmed cell death, termed oxytosis (19) , is initiated by the addition of glutamate to the extracellular medium. Glutamate then inhibits the uptake of cystine, which is required for GSH synthesis (20), resulting in the depletion of GSH in neurons (15, (21) (22) (23) ). Subsequently, this decrease in cellular GSH results in the production of ROS by mitochondria. The production and accumulation of ROS proceed in two phases: an initial slow increase up to five to tenfold of the control level, followed by an explosive generation up to two hundred times greater than the control level. The higher rate of ROS increase begins after the cellular GSH levels fall below 20% of the control (18) . The importance of mitochondria in ROS production is supported by the observation that the mitochondrial uncoupler cyanide p-trifluoromethoxyphenylhydrazone (FCCP) and other mitochondrial inhibitors protect neuronal cells from glutamate toxicity (18) . The ROS accumulation then causes Ca 2+ influx from the extracellular medium, which leads to cell death. The central role of ROS in this cell death cascade is evidenced by the observation that exogenously-added antioxidants such as vitamin E and propyl gallate (PG) (Fig. 1 ) protect cells from glutamate toxicity (15, 18, 21, 24) . In addition to the elucidation of the steps involved in oxytosis, HT-22 cells have been used to screen potentially therapeutic drugs for the treatment of clinical conditions involving oxidative stress (24) (25) (26) (27) (28) .
The tyrphostins are a family of structurally related phenolic compounds that inhibit protein tyrosine kinases (PTKs) (29, 30) . Because the elevated activities of specific PTKs may cause cancers and other proliferative disorders, Levitzki and his coworkers synthesized a variety of tyrphostins from tyrosine and erbstatin (29, 31) . Thus, some tyrphostins inhibit specific PTKs such as the EGF receptor without affecting other PTKs such as the insulin receptor (32) . Because of their selective inhibition and low toxicity (33) , tyrphostins may have therapeutic value for the treatment of pathological conditions caused by the excessive activity of specific PTKs (34) . However, some tyrphostins appear to affect not only PTKs but also other enzymes and biological functions independent of their effects on PTKs. For by guest on November 17, 2017 http://www.jbc.org/ Tyrphostins 4 example, tyrphostins can affect phosphodiesterases (35, 36) , calcium entry in Jurkat T cells (37) , and mitochondrial membrane potential in HL-60 cells (38) independently of their effects on PTKs.
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Protection of Neuronal Cells by
Tyrphostins generally have a phenolic structure which closely resembles that of antioxidants such as vitamin E and PG (Fig. 1 ). Because these latter compounds protect HT-22 cells from oxidative glutamate toxicity, we decided to test the protective efficacy of tyrphostins in this system. We report here that many tyrphostins protect the nerve cell line HT-22, as well as rat primary neurons, from cell death induced by oxidative glutamate toxicity. Additionally, tyrphostins protect nerve cells from oxidative injury caused by homocysteic acid and buthionine sulfoximine. The protection by tyrphostins is independent of their ability to inhibit tyrosine kinases. Instead, three distinct mechanisms appear to be involved in the protection of the nerve cells from oxidative stress-induced cell death. First, some tyrphostins (A23 and A25, for example) protect the nerve cells by acting as antioxidants. This conclusion is derived from the ability of these tyrphostins to quench free radicals both in a cell-free system and directly in nerve cells which have accumulated high levels of ROS. Second, many tyrphostins induce γ-glutamylcysteine synthetase, the rate-limiting enzyme in GSH biosynthesis, resulting in an increased basal GSH level and protection of the cells. Third, tyrphostins A9 and AG126 protect cells from glutamate toxicity by their ability to decrease the mitochondrial membrane potential, which results in a decrease in ROS production following glutamate treatment. Thus, many tyrphostins possess additional, important biological activities that are independent of their ability to inhibit PTKs. 
EXPERIMENTAL PROCEDURES Chemicals
Tyrphostins were purchased from Alexis (San Diego, CA) or CalBiochem (San Diego, CA).
Because of stability issues (39, 40) , stock solutions of tyrphostins were prepared in 100% DMSO and kept in the dark at -20˚C. 2', 7'-dichlorodihydrofluorescein diacetate (H 2 DCF-dA), indo-1, Pluronic 127, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benzimidazolcarbocyanine iodide (JC-1), DAPI, and rhodamine-123 were purchased from Molecular Probes (Eugene, OR). All other chemicals were from Sigma (St. Louis, MO).
Cell Culture
Fetal bovine serum (FBS) and dialyzed FBS were from Hyclone (Irvine, CA). Dulbecco's Modified Eagle's Medium (DMEM) was purchased from Gibco BRL (Life Technologies, Rockville, MD). HT-22 cells (15, 16) were derived from the immortalized mouse hippocampal cell line, HT-4 (41), and were grown on tissue culture dishes (Falcon, Indianapolis, IN) in DMEM supplemented with 10% FBS. Pancreatin (Life Technologies, Rockville, MD) was used to dissociate the cells from the culture dishes. Short-term cultures of primary cortical neurons from 17-day-old rat embryos were prepared according to Abe and Kimura (42) . The primary cells were used for experiments within three days after plating and do not express functional ionotropic glutamate receptors.
Cytotoxicity Assay
Cell viability was determined by a modified version of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (43, 44 ) based on the standard procedure (45) . Briefly, cells were seeded onto 96-well microtiter plates at a density of 2.0 x 10 3 cells per well in 100 µl of 10% dialyzed FBS (DFBS). The next day, cells were treated with various protective reagents for 30 minutes prior to the addition of a toxic agent (glutamate, HCA, and BSO). Twenty four hours after the addition of a toxic agent, the cell culture medium in each well was aspirated and replaced with fresh 10% DFBS containing 2.5 µg/ml MTT. After 4 hours of incubation at 37˚C, cells were solubilized with 100 µl of a solution containing 50% dimethylformamide and 20% SDS (pH 4.7). The absorbance at 560 nm was measured on the following day with a microplate reader (ICN Flow Titertec Multiskan PLUS -Mk 11).
Results obtained from the MTT assay correlated directly with the extent of cell death as confirmed visually (see, for example, Fig. 2 ) as well as the LDH release assay (data not shown).
For hydrogen peroxide (H 2 O 2 ) toxicity, cells were pre-incubated with a tyrphostin for 30 minutes before the addition of H 2 O 2 . Two hours later, the cell culture medium was aspirated and replaced with a fresh medium. The next day, cell viability was assessed by the MTT assay as described above.
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Microscopy
A light microscope (Inverted Microscope Diaphot-TMD, Nikon, Japan) equipped with a phase contrast condenser (Phase contrast-2 ELWD 0.3, Nikon, Japan), 10X objective lens, and a digital camera (Coolpix 990, Nikon, Japan) was used to capture the images with the manual setting.
Total Intracellular GSH/GSSG
Cells were washed twice with ice-cold PBS, collected by scraping, and lysed with 3% sulfosalicylic acid. Lysates were incubated on ice for 10 minutes and supernatants were collected after centrifugation in an Eppendorf microfuge. Upon neutralization of the supernatant with triethanolamine, the concentration of total glutathione (reduced and oxidized) was determined by the method of Tietze (46) with modifications (24) . Briefly, a neutralized supernatant from above (25 µl) was mixed with 175 µl of a reaction mixture containing 143 mM sodium phosphate (pH 7.5), 6.3 mM Na 4 EDTA, 6 mM 5,5'-dithiobis(2-nitrobenzoic acid), and 0.25 mg/ml NADPH. The reaction was started by adding 1 unit/ml of glutathione reductase. Color development was monitored at 405 nm in a kinetic mode with a microplate reader (ICN Flow Titertec Multiskan PLUS -Mk 11). Pure GSH was used to obtain a standard curve. The protein content of each sample was determined using the BCA Protein Assay kit from Pierce (Rockford, IL) with BSA as a standard.
Reactive Oxygen Species (ROS) Level
The intracellular accumulation of ROS in HT-22 cells was determined with H 2 DCF-dA (44). Cells were washed once with DMEM supplemented with 10% FCS to remove test compounds before loading with 5 µg/ml JC-1 for 20 minutes at 37 ˚C. The cells were then dissociated with 1 x trypsin/EDTA, centrifuged, and washed once with DMEM lacking phenol red. Cell pellets were resuspended in DMEM without phenol red and DAPI (2 µg/ml) was added to the samples to allow the gating out of dead cells. Flow cytometric analysis was performed using a LSR 3-laser 6-color analytic flow cytometer (Becton-Dickinson, San Jose, CA, USA). λex = 475 nm, λem = 530 nm (the monomer JC-1), and λem = 585 nm (the aggregate JC-1); λex = 345 nm, λem = 455 nm for DAPI.
Determination of Mitochondrial Membrane Potenital
Determination of the Trolox Equivalent Activity Concentration (TEAC)
Values of TEAC for tyrphostins and other compounds were determined according to Rice-Evans and Miller (24, 50) . Briefly, 150 µM 2,2'-azinobis(3-ethylbenzothiazoline 6-sulfonate)(ABTS), 2.5 µM metomyoglobin, and 75 µM H 2 O 2 were mixed in Dulbecco's phosphate buffered saline solution. Then, the change in absorbance due to the formation of the ABTS free radical was measured at 734 nm for 7.5 min. The inhibition of this free radical formation by the inclusion of 1.0 mM Trolox in the assay solution was used as a basis for the determination of TEAC values for tyrphostins and other compounds.
Tyrosine Kinase Assay
Protein tyrosine kinase activity was measured on extracts from untreated and tyrphostin-treated HT-22 cells exactly as described (51) . Briefly, cells on 60 mm dishes were scraped into 500 µl of 50 mM Tris-HCl, pH 7.4 containing 2 mM MgCl 2 , 1 mM EDTA, 1 mM Na 2 VO 4 and 1 mM PMSF and were lysed by sonication. Following centrifugation for 10 min at 16,000 x g at 4 o C, 20 µl of each supernatant was assayed for protein tyrosine kinase activity in a total volume of 50 µl containing 50 mM Tris-HCl, pH 7.4, 10 mM MgCl 2 , 10 mM MnCl 2 , 50 µM Na 2 VO 4 , 50 µM ATP (Sigma), 2 µCi γ- To quantify the amount of 32 P incorporated into the poly amino acid substrate, the section of each lane containing the radiophosphorylated substrate was cut out and counted in a scintillation counter (Cerenkov counts). Control reactions containing the cell extracts but no substrate were run in parallel and the counts from these lanes were subtracted from those containing the substrate. The results were normalized to the amount of protein in each extract as determined using the BCA protein assay. Similar results were obtained when overall protein tyrosine phosphorylation was measured using immunoblotting with anti-phosphotyrosine antibodies (data not shown). 
Immunoblot
For Western blotting, cells from subconfluent cultures were washed twice in cold phosphatebuffered saline (PBS) then scraped into lysis buffer containing 50 mM HEPES, pH 7.4, 150 mM NaCl, 50 mM NaF, 1.5 mM MgCl 2 , 1 mM EGTA, 10% glycerol, 1% Triton X-100, 10 mM sodium pyrophosphate, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride (PMSF), 15 µg/ml aprotinin, 1 µg/ml pepstatin, and 5 µg/ml leupeptin. Lysates were incubated at 4 °C for 30 min, then cleared by centrifugation at 14,000 rpm for 10 min. Protein concentrations were determined using the BCA protein assay (Pierce, Rockford, IL). Equal amounts of protein were solubilized in 2.5X SDS-sample buffer, separated on 10% SDS-polyacrylamide gels and transferred to nitrocellulose. Transfers were 
Statistical Analysis
Experiments presented were repeated at least three times with triplicate samples. The data are presented as means ± SEM. 
RESULTS
Protection from Glutamate Toxicity
Glutamate kills the hippocampal cell line HT-22 by a mechanism that involves the accumulation of ROS (15, 18) . This system is useful for screening chemical compounds that are protective against glutamate toxicity and other oxidative insults (15, 24, 26) . As shown in Figure While some tyrphostins (A9, A23, and A25) were very effective in protecting the HT-22 cells from oxidative glutamate toxicity, other tyrphostins were either less effective or completely ineffective.
To directly compare the protective efficacy of the different tyrphostins, HT-22 cells were exposed to 5 mM glutamate in the presence of various concentrations of each tyrphostin and after 24 hours, cell viability was determined by the MTT assay (Fig. 3C ). Tyrphostin A25 has an effective half maximal concentration for protection (EC 50 ) of 6 µM, and maximal protection is observed with concentrations higher than 10 µM (Fig. 3C ). Tyrphostin A9 is more effective than A25; the EC 50 for A9 is 0.2 µM, and maximal protection is achieved at 1 µM (Fig. 3C ). Among the less effective tyrphostins are A1, which is commonly used as a negative control for the tyrosine kinase inhibitory activity of other tyrphostins (29) , and AG10 ( Fig. 3A and 3C ), both of which have effective half maximal concentrations for protection 8-15 fold higher than A25. Other tyrphostins, such as RG13022 and RG14620, are completely ineffective at protecting cells from oxidative stress ( Table-1 ). These results suggest certain structural requirements for protection from oxidative stress and will be addressed further in the Discussion.
Protection from HCA and BSO Table-1 ). This trend is particularly pronounced in tyrphostins that are only moderately efficacious against glutamate ( Table-1 ). For example, tyrphostin AG10 is only weakly protective against HCA ( Fig. 4A) but it is not possible to achieve greater levels of protection due to the toxicity of the compound at higher concentrations. Therefore, the EC 50 values for tyrphostins A1 and AG10 against HCA toxicity were not determined ( Table-1 ).
Unlike HCA, BSO decreases cellular GSH by inhibiting the GSH synthetic enzyme γ-glutamylcysteine synthetase (γ-GCS) (52) . As shown in Fig. 4B , viability decreases to 7% when cells are treated with 50 µM BSO. The protection profile of many tyrphostins against BSO is similar to that against HCA. For instance, tyrphostins A23 and A25 protect HT-22 cells from BSO at concentrations that are higher than those that are required for protection against glutamate toxicity ( Fig. 4B ; Table-1 ).
In addition, tyrphostins A1, AG10, and AG1295 are not effective against BSO toxicity ( Fig. 4B ; Table- 1). However, tyrphostins A9, AG126, and AG1288 behave very differently in BSO toxicity as compared with HCA toxicity. In the presence of 5 µM BSO cell viability is 80%, which is reduced to 3% if 0.5 µM tyrphostin A9 is added (Fig. 4B ). AG126 also potentiates BSO toxicity when added at concentrations of 80 µM or higher (data not shown). AG1288 neither protects nor potentiates BSO toxicity at concentrations up to 200 µM (data not shown). In summary, some tyrphostins protect HT-22 cells to varying degrees from reagents that decrease cellular GSH. Tyrphostins exemplified by A25 protect HT-22 cells from glutamate, HCA, and BSO, all of which decrease cellular GSH. Another class of tyrphostins (tyrphostins A1, AG10, and AG1295) has a low efficacy against glutamate and HCA and is ineffective against BSO. Finally, tyrphostins A9, AG126, and AG1288 protect cells from glutamate and HCA in the low micromolar range but both tyrphostins A9 and AG126 potentiate BSO toxicity while tyrphostin AG1288 is not protective against BSO.
Inhibition of Tyrosine Kinase Activity
To characterize further the mechanism of protection from oxytosis by tyrphostins, we initially focused on the fact that tyrphostins were originally designed to inhibit tyrosine kinases (30) . Thus, the mechanism of cellular protection by tyrphostins could be attributable to their ability to inhibit a tyrosine (Table-1) . As the first step to determine if tyrosine kinase inhibition is important in the protection of cells from glutamate toxicity by the tyrphostins, inhibition of total tyrosine kinase activity was measured in cells treated with the tyrphostins (Fig. 5 ). There is no correlation between the efficacy of protection against glutamate toxicity and the inhibition of total tyrosine kinase activity. For example, total tyrosine kinase activity is inhibited to a similar level by 10 µM A25, 0.5 µM A9, 10 µM RG13022, and 100 µM AG1295. While the former two tyrphostins protect HT-22 cells from glutamate toxicity at these concentrations, AG1295 is protective only at high concentrations and RG13022 is not protective at any concentration tested (Table-1) . Furthermore, genistein, a general tyrosine kinase inhibitor (53), decreases the total protein tyrosine kinase activity to 34.1% and 24% of the control level when present at 100 µM and 300 µM, respectively. Genistein at 100 µM does not protect against glutamate toxicity but in the presence of 300 µM genistein, 67% of the cells survive. These data do not eliminate unequivocally the possibility that tyrphostins protect HT-22 cells by inhibiting a tyrosine kinase whose activity may be a minor component of the total tyrosine kinase activity present in the cell free system used here. However, the fact that many tyrphostins with various specificities to PTKs protect neuronal cells from pro-oxidants argues against a protective mechanism involving the inhibition of a specific tyrosine kinase. Also, when considered along with the results described below, protection by tyrphostins appears unlikely to involve the inhibition of a tyrosine kinase.
GSH Metabolism
Glutamate and HCA inhibit cystine uptake in HT-22 cells, resulting in the total loss of the cellular GSH within 8 hours (15, 18) . Some compounds that protect HT-22 cells from these toxic agents do so by increasing the basal level of cellular GSH (24, 26) . To determine if any of the protective tyrphostins alter the basal metabolism of GSH, HT-22 cells were treated with each tyrphostin for 17 hours, harvested, and total GSH was determined. As shown in (Table-2 ). Higher concentrations of tyrphostins A1, AG10, and A25 progressively increase the cellular GSH levels, while tyrphostin A9 further decreases the cellular GSH levels at higher concentrations (Fig. 6B) . The changes in GSH levels are observed within 8 hours of tyrphostin addition (Fig. 6C) .
To determine if the up-regulation of basal GSH induced by tyrphostins is also observed during glutamate toxicity, cells were treated with a toxic dose of glutamate in the presence of protective tyrphostins for 24 hours and total GSH was determined. The cells treated with glutamate for 24 hours lose all of their GSH (Fig. 6A, (15) ). In contrast, the cells maintain 30 -60% of the GSH level of untreated cells if protective tyrphostins are included at the beginning of the incubation with glutamate (Fig. 6A) . Even tyrphostin A9 and FCCP, which decrease the basal level of GSH, maintain the cellular GSH level during glutamate treatment (Fig. 6A) . To see if the rate of GSH decrease is also affected by the protective tyrphostins during glutamate toxicity, HT-22 cells were harvested for the determination of total cellular GSH every two hours after the addition of glutamate and tyrphostins (Fig. 6D) . The cells lose 90% of their GSH within 10 hours of glutamate addition (Davis, 1994 . In contrast, cells treated with protective tyrphostins have slower rates of GSH loss. Even cells treated with tyrphostin A9 and FCCP, both of which decrease the basal level of GSH (Fig. 6A) , show a decrease in the rate of GSH loss caused by glutamate (Fig. 6D) . Therefore, protective tyrphostins increase basal GSH and/or they maintain cellular GSH levels in the presence of glutamate, which likely contributes to cellular protection.
ROS Levels
When more than 80% of the cellular GSH is depleted following glutamate treatment, mitochondria produce ROS, which accumulate to levels up to 100 fold above control values (18) . The critical role of ROS accumulation in the cell death cascade is shown by the fact that antioxidants such as vitamin E and PG protect HT-22 cells from glutamate despite the loss of cellular GSH (15, 24) . Because tyrphostins contain a phenolic functional group similar to other antioxidants ( Fig. 1) , tyrphostins could block ROS production during oxytosis. HT-22 cells were treated with a toxic dose of glutamate in the presence of a tyrphostin for 12 hours. Then, the cells were loaded with the fluorescent probe DCF, and the level of ROS accumulation was measured by flow cytometry (15, 18) . The mean DCF fluorescence increases dramatically in the HT-22 cells treated with glutamate ( Fig. 7A ; compare "control" to "Glu"). If the antioxidant PG is added to the cells along with glutamate, the DCF fluorescence level after 12 hours is greatly decreased ( Fig. 7A ; "PG + Glu") (15, 24) . Tyrphostin A25 prevents the increase in the DCF fluorescence caused by glutamate treatment similarly to PG ( Fig. 7B ; compare "A25 + Glu" to "Glu"). All other protective tyrphostins such as A1 (Fig. 7C) , A9 (Fig. 7D) , and A23
(data not shown) also prevented the increase in DCF fluorescence caused by glutamate treatment if these tyrphostins were present at the start of the treatment. 
Antioxidant Efficacy
Since the above experiment does not distinguish between direct antioxidant activity and inhibition of a step required for ROS production, we asked if tyrphostins can directly quench endogenously produced ROS which have accumulated within the cell. HT-22 cells were treated with glutamate for 11 hours, a time point at which the cells are still alive but have accumulated high levels of ROS ( Fig. 7A; (18) ). Then, tyrphostins were added to these cells in the presence of glutamate for an additional 1 hour before the determination of ROS levels by DCF fluorescence (24) using flow cytometry. As shown in the previous section, HT-22 cells accumulate high levels of ROS after a twelvehour incubation with 5 mM glutamate (Fig. 7A , "Glu") compared to the control sample treated only with the antioxidant propyl gallate (PG) (Fig. 7A, " PG"). HT-22 cells treated with PG and 5 mM glutamate accumulate lower levels of ROS after 12 hours (Fig. 7B , "Glu + PG"). PG can also act directly as an antioxidant as shown by its ability to decrease the level of ROS already accumulated inside the cells ( To examine further the possible antioxidant capacity of tyrphostins, the Trolox Equivalent Activity Concentration (TEAC) (50) of tyrphostins was determined in order to quantify their efficacy as antioxidants in a cell-free system. In this well-established procedure, a substance is compared to Trolox, a water-soluble vitamin E analog, in its ability to suppress the radical cation of ABTS in an aqueous solution (55) . Many tyrphostins have TEAC values higher than Trolox, indicating that they can act as antioxidants ( Table-1 Fig. 8B ). This observation, in addition to the results presented in the previous section ( Fig. 7 ; Table- In contrast, tyrphostins A9 and AG126 potentiate H 2 O 2 toxicity (Fig. 8A) . The potentiation is obvious by light microscopic observation within 10 minutes of H 2 O 2 addition (Fig. 8C) . We speculated that this could be due to an effect of these tyrphostins on the mitochondrial membrane potential (38) similar to FCCP. To provide further evidence for this idea, mitochondrial inhibitors were tested in H 2 O 2 toxicity. FCCP, which depolarizes mitochondria and protects HT-22 cells from glutamate toxicity (18), strongly potentiates H 2 O 2 toxicity in a manner similar to tyrphostin A9 (Fig. 8C) . Other mitochondrial inhibitors such as rotenone and antimycin A also potentiate H 2 O 2 toxicity (Table-1 ).
Protection by Collapsing Mitochondrial Membrane Potential
To directly determine if tyrphostins A9 and AG126 can alter the mitochondrial membrane potential, HT-22 cells were treated with these tyrphostins and the mitochondrial membrane potential was determined fluorometrically using JC-1. JC-1 accumulates in mitochondria as the result of the membrane potential and forms aggregates, resulting in a shift of the fluorescence emission wavelength from 527 nm (monomer fluorescence) to 590 nm (aggregate fluorescence) (56) . As shown in Fig. 9 , neither tyrphostin A1 nor A25 alter the ratio between the monomer and aggregate fluorescence of JC-1.
In contrast, tyrphostins A9 ( 
DISCUSSION
The above results show that many tyrphostins protect nerve cells from oxidative stress induced by glutamate as well as by HCA, BSO, and H 2 O 2 . Using glutamate toxicity as a well-characterized model of oxidative injury, we determined the structural requirements of tyrphostins necessary to protect nerve cells from death. We found that tyrphostins protect nerve cells from oxidative stress by three distinct mechanisms: altering GSH metabolism, acting as antioxidants, and decreasing the mitochondrial membrane potential, thereby reducing the production of ROS after glutamate treatment. In some cases, the same tyrphostin protects by more than one mechanism. For example, A25 not only acts as an antioxidant but also increases the basal level of cellular GSH.
Structural Requirements for Protection
Because tyrphostins protect nerve cells from glutamate toxicity by at least three distinct mechanisms, it is difficult to arrive at a single structure-activity relationship for their protective efficacy.
However, two main structural determinants appear to control the efficacy of protection: the hydroxyl groups and hydrophobicity.
The Hydroxyl Groups
The hydroxyl group on the benzene ring of the tyrphostins is critical for the protection of HT-22 cells from oxidative stress. Indeed, all tyrphostins that are protective against glutamate, HCA, and BSO contain at least one hydroxyl group. Thus, tyrphostins without a hydroxyl group (A1, RG13022, RG14620, and AG1295) are either non-protective or require very high concentrations to achieve even partial protection. Furthermore, the efficacy of protection improves with an increased number of hydroxyl groups. For example, as the number of hydroxyl groups increases from tyrphostin AG10 to A23 to A25, so does the protective efficacy against glutamate and other pro-oxidants ( 
Hydrophobicity
In general, the more hydrophobic a tyrphostin, the better its protective efficacy against oxidative stress. For example, the protective potency of tyrphostin A23 is increased if the substituent group on the R4 position is more hydrophobic than the nitrile group on A23. Thus, AG114, 213, 494, and 556 have EC 50 values lower than that of A23, with AG556 being the most hydrophobic and the most efficacious (EC 50 = 1) of the group (Table-1 ). This dependence of protective efficacy on hydrophobicity can be seen more clearly in HCA and BSO toxicity. Tyrphostins AG114, 213, 494, and 556 are all more protective than A23 against HCA and BSO toxicity ( Table-1 ). Likewise, the protective efficacy against oxidative stress decreases as the hydrophilicity of the substituent group on the R4 position increases.
For example, the substitution of the two nitrile groups in tyrphostin A23 with one hydrogen and the hydrophilic carboxylic acid group results in caffeic acid (3,4-dihydroxycinnamic acid). Caffeic acid does not protect HT-22 cells from glutamate, HCA, or BSO unless the carboxylic acid is esterified to reduce hydrophilicity (24) . In general, hydrophobic polyphenolic antioxidants are more protective against oxidative stress (24) and amyloid beta toxicity (57) than their more water-soluble counterparts.
This dependence on hydrophobicity is probably due to the enhanced ability of hydrophobic compounds to penetrate lipid bilayers in order to reach the sites of ROS generation (mitochondria) and accumulation (the cytoplasm) (24) .
Other Functional Groups
Two other functional groups that alter the properties of tyrphostins are the nitro group and the tbutyl group on the phenolic ring. The presence of the nitro group decreases the efficacy of protection against all of the pro-oxidants tested. For instance, AG1288 is identical to A23 in structure except for the nitro group at the R1 position (Table-1 ). Tyrphostin AG1288 is half as efficacious as A23 against glutamate, HCA, and H 2 O 2 . This difference may be attributable to the nitro group destabilizing either the reaction intermediate or the product after reaction with ROS. The presence of the t-butyl group, as seen in tyrphostin A9, has a much more dramatic impact on both the protection profile and the mechanism of protection (see below).
In contrast, the structural determinants of the tyrphostins that are important for protection against oxidative stress do not appear to be as critical for tyrosine kinase inhibition. For example, tyrphostins A23 and A24, both of which have two hydroxyl groups, protect similarly against glutamate, HCA, and BSO but show a sixfold difference in the IC 50 for inhibition of EGFR kinase activity (Table-1) . Similarly, there is no direct correlation between the hydrophobicity of a tyrphostin and its IC 50 for inhibition of tyrosine kinase activity (compare, for example, AG18 to AG1288).
Mechanisms of Protection
Tyrphostins protect HT-22 cells from oxytosis induced by glutamate at three distinct steps in the cell death cascade: GSH metabolism, the generation of ROS from mitochondria, and the accumulation of by guest on November 17, 2017
http://www.jbc.org/ Downloaded from ROS in the cell. Since the initial insult in glutamate toxicity is a decrease in the level of the endogenous antioxidant GSH (21), the up-regulation of GSH metabolism may provide protection from glutamate toxicity. Indeed, many tyrphostins increase the basal GSH level which correlates quite well with their protective efficacies ( Fig. 6 ; Table-2) . A similar mechanism of protection due to an increase in GSH levels is observed with some flavonoids and gallic acid esters (24) and with the metabotropic glutamate receptor agonist, DHPG (26) . Such an increase in the basal level of GSH is often caused by the upregulation of the rate-limiting enzyme for GSH metabolism, γ-GCS (Fig. 6A, insert) (24, 54, 58) . It has been shown previously that the upstream region of the γ-GCS catalytic gene contains an antioxidant response element (ARE) (59) and some tyrphostins may be able to activate this promoter. The upregulation of enzymes involved in GSH metabolism is an important mechanism of protection against oxidative stress and other toxic insults. For example, cells that have acquired resistance to pro-oxidants such as glutamate have increased levels of the GSH metabolic enzymes γ-GCS, glutathione reductase, and glutathione peroxidase (54, 60) . These cells also have an increased tolerance to H 2 O 2 .
The control of GSH metabolism alone, however, is unlikely to be sufficient for the protection of cells from oxidative stress by tyrphostins. This conclusion is based on two observations. First, tyrphostin A1 at low concentrations does not protect the HT-22 cells from glutamate toxicity, even though the basal GSH level is increased by these same concentrations of A1 (Fig. 6B) . Second, many tyrphostins are protective against both glutamate and BSO. Since BSO inhibits γ-GCS, the induction of this enzyme cannot be protective against BSO. Tyrphostins may, however, induce a subset of genes that contain the ARE. For example, the induction of quinone reductase, whose gene contains the ARE, is protective against glutamate toxicity (61).
In addition to the effect on GSH metabolism, many tyrphostins protect cells by acting as antioxidants and scavenging accumulated ROS. This conclusion is supported by four pieces of evidence. First, analogous to the antioxidants propyl gallate ( Fig. 7 ; (24)) and vitamin E (15), the antioxidant tyrphostins maintain low levels of ROS in the cells in the presence of glutamate (Fig. 7) .
Second, these compounds are also able to remove ROS that have already accumulated in cells (Fig. 7) .
Third, the TEAC values of these compounds indicate the potential to act as antioxidants (Table-1) .
Fourth, these tyrphostins also protect HT-22 cells from H 2 O 2 ( Fig. 8 ; Table-1) .
The third mechanism of protection was observed with tyrphostins A9 and AG126 (Table-2) . As noted before, these tyrphostins do not act as antioxidants (Table-1 ; Fig. 7, 8 ) nor do they increase the basal level of GSH as seen with tyrphostins A1 and A25 (Fig. 6A) . Instead, these tyrphostins act on mitochondria, resulting in a lower accumulation of ROS during glutamate toxicity. This conclusion is based on the observation that these tyrphostins decrease the mitochondrial membrane potential similarly to the mitochondrial uncoupler FCCP (Fig. 9) . Additionally, these tyrphostins protect cells from glutamate and HCA in the low micromolar range, while they potentiate BSO and H 2 O 2 toxicity ( Fig. 4B ; Fig. 8A ; Table-1) . FCCP and other mitochondrial inhibitors show similar protection and potentiation profiles ( Table-1 ). Burger and coworkers also found tyrphostin A9 to decrease the membrane potential of mitochondria (38) . (Fig. 7) but it also prevents the GSH loss caused by glutamate (Fig. 6D) . These data suggest that mitochondrial activity consumes the majority of cellular GSH and that, in the absence of GSH, mitochondria actively produce a large amount of ROS, ultimately resulting in cell death.
In addition to the characterization of three distinct mechanisms of protection by tyrphostins, this study highlights subtle differences in pro-oxidants. For example, HCA kills the cells more effectively than glutamate, even though these compounds inhibit cystine uptake equally (62) . Consequently, higher concentrations of tyrphostins are required to protect cells from HCA than from glutamate ( Table-1 ).
This difference may be attributable to the presence of glutamate-specific transporters on the cell surface which reduce the glutamate concentration in the medium. Without such a transporter, HCA may remain in the medium and inhibit cystine uptake more effectively than glutamate.
More striking differences are shown between glutamate and BSO. Both glutamate and BSO decrease cellular GSH at a similar rate (18) . However, mitochondrial inhibitors such as FCCP and tyrphostin A9 potentiate BSO toxicity while they protect cells from glutamate (Fig. 3, Fig. 4B , Table-1) .
This difference may stem from the different roles of mitochondria in the death caused by these prooxidants. As noted above, glutamate induces the hyperpolarization of mitochondria, resulting in ROS generation. Therefore, inhibition of mitochondria (or depolarization) decreases the generation and accumulation of ROS (18) . Also, cytochrome c is not released during glutamate toxicity (unpublished observation). In contrast, depolarization of mitochondria is observed in BSO toxicity under some conditions (63) along with the release of cytochrome c (64, 65) . As a consequence, cells do not produce an appreciable amount of ROS (18, 66 HT-22 cells were exposed to various concentrations of a tyrphostin to determine the half maximal lethal dose LD 50 (µM) using the MTT assay. 
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